• Publications
  • Influence
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
TLDR
The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported. Expand
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
TLDR
Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. Expand
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
TLDR
In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care, and future trials in patients withsevere illness may help to confirm or exclude the possibility of a treatment benefit. Expand
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
TLDR
In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits, however, the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies. Expand
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
TLDR
The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity. Expand
Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study
TLDR
Severe and critical patients with COVID-19 have a high risk of malnutrition and early nutritional risk screening and therapy for patients with the disease are necessary. Expand
Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus
TLDR
Cardiac injury is a frequent condition among hospitalized patients infected with influenza A (H7N9) virus, and it is associated with higher risk of mortality during hospitalization, andMultivariable-adjusted Cox proportional hazards regression analysis showed that cardiac injury was associated withHigher mortality duringhospitalization. Expand
Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection.
TLDR
Favipiravir and oseltamivir combination therapy may accelerate clinical recovery compared to oselTAMivir monotherapy in severe influenza, and this strategy should be formally evaluated in a randomized controlled trial. Expand
Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection
TLDR
These findings suggest that NAI treatment should be started as soon as possible in patients with suspected A(H7N9) infection and that use of corticosteroids should be prudent. Expand
Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus
TLDR
This research presents a novel probabilistic approach that allows us to assess the importance of knowing the carrier and removal status of canine coronavirus, as a source of infection for other animals. Expand
...
1
2
3
4
...